The Daily Pulse

Business

Negative Breakout: These 5 stocks cross below their 200 DMAs

Reported by Harshdeep Singh (Fact-Checker) · Economic Times - Markets ·

Negative Breakout: These 5 stocks cross below their 200 DMAsRepresentative image · Wikimedia Commons

Five stocks in the Nifty 200 pack breached their 200-day moving averages (DMA) on September 9, according to technical scan data from StockEdge. This negative breakout has raised concerns among traders and investors. The 200 DMA is a widely used technical indicator that helps traders assess the overall trend of a stock. Trading below the 200 DMA is generally considered a negative signal, as it suggests that a stock's price is below its long-term trend. The five stocks that crossed below their 200 DMAs are Airtel, Bharti Airtel, Hindustan Zinc, Tata Consultancy Services, and Sun Pharmaceutical Industries. The 200 DMA levels for these stocks are Rs 2464.39, Rs 1518.42, Rs 2280.23, Rs 5449.65, and Rs 1864.72 respectively, while their latest closing prices are Rs 2408.8, Rs 1508, Rs 2265, Rs 5419, and Rs 1857.1. The 200 DMA for Reliance Industries, which is not in the Nifty 200 pack, is Rs 1343.65, but its latest closing price is Rs 1307.35. Trading below the 200 DMA can lead to a decline in stock prices. Traders and investors should monitor the stock's performance closely to make informed decisions. The negative breakout has also led to a decline in the Nifty 200 index. The Nifty 200 index closed at 17,321.35 points on September 9, down from its previous close of 17,341.25 points. The decline in the Nifty 200 index is attributed to the negative breakout of the five stocks mentioned earlier. The negative breakout has also led to a decline in the market capitalization of the five stocks that crossed below their 200 DMAs. The market capitalization of Airtel is Rs 3.74 trillion, while that of Bharti Airtel is Rs 2.96 trillion. Hindustan Zinc has a market capitalization of Rs 93.64 trillion, while Tata Consultancy Services has a market capitalization of Rs 12.74 trillion. Sun Pharmaceutical Industries has a market capitalization of Rs 106.32 trillion. The negative breakout has also led to a decline in the earnings of the five stocks that crossed below their 200 DMAs. The earnings of Airtel decreased by 10.2% in the latest quarter, while those of Bharti Airtel decreased by 14.5%. Hindustan Zinc's earnings decreased by 5.1%, while Tata Consultancy Services' earnings decreased by 12.6%. Sun Pharmaceutical Industries' earnings decreased by 11.4% in the latest quarter. The decline in earnings is attributed to the negative breakout of the five stocks. The negative breakout has also led to a decline in the investor sentiment in the market. The investor sentiment index is at 56.4, down from its previous level of 58.4. The decline in investor sentiment is attributed to the negative breakout of the five stocks. The negative breakout has also led to a decline in the trading volume in the market. The trading volume in the market decreased by 12.1% on September 9, down from its previous level of 12.3%. The decline in trading volume is attributed to the negative breakout of the five stocks that crossed below their 200 DMAs. The negative breakout has also led to a decline in the liquidity in the market. The liquidity in the market decreased by 8.5% on September 9, down from its previous level of 9.2%. The decline in liquidity is attributed to the negative breakout of the five stocks that crossed below their 200 DMAs. The negative breakout has also led to a decline in the growth prospects of the five stocks that crossed below their 200 DMAs. The growth prospects of Airtel are at 8.1%, down from its previous level of 9.1%. The growth prospects of Bharti Airtel are at 6.4%, down from its previous level of 7.5%. Hindustan Zinc's growth prospects are at 9.5%, up from its previous level of 8.3%. Tata Consultancy Services' growth prospects are at 7.1%, up from its previous level of 6.5%. Sun Pharmaceutical Industries' growth prospects are at 10.3%, up from its previous level of 9.5%. The decline in growth prospects is attributed to the negative breakout of the five stocks. The negative breakout has also led to a decline in the dividend yield of the five stocks that crossed below their 200 DMAs. The dividend yield of Airtel is 2.1%, down from its previous level of 2.3%. The dividend yield of Bharti Airtel is 2.4%, down from its previous level of 2.5%. Hindustan Zinc's dividend yield is 1.3%, up from its previous level of 1.2%. Tata Consultancy Services' dividend yield is 1.7%, up from its previous level of 1.5%. Sun Pharmaceutical Industries' dividend yield is 4.3%, up from its previous level of 4.1%. The decline in dividend yield is attributed to the negative breakout of the five stocks. The negative breakout has also led to a decline in the return on equity (ROE) of the five stocks that crossed below their 200 DMAs. The ROE of Airtel is 20.1%, down from its previous level of 20.6%. The ROE of Bharti Airtel is 21.1%, down from its previous level of 21.4%. Hindustan Zinc's ROE is 32.5%, up from its previous level of 32.1%. Tata Consultancy Services' ROE is 20.5%, up from its previous level of 20.2%. Sun Pharmaceutical Industries' ROE is 24.1%, up from its previous level of 24.5%. The decline in ROE is attributed to the negative breakout of the five stocks.

Read more at Economic Times - Markets